Видео ютуба по тегу Crisprstock

Crispr Therapeutics CEO: Science in gene editing is moving at break-neck speed
Crispr Therapeutics CEO: Science in gene editing is moving at break-neck speed
CRISPR Therapeutics (CRSP STOCK): HUGE INSIDER BUY! 100% UPSIDE?
CRISPR Therapeutics (CRSP STOCK): HUGE INSIDER BUY! 100% UPSIDE?
CRISPR-based gene editing revolutionized medicine—what's next?
CRISPR-based gene editing revolutionized medicine—what's next?
Crispr Therapeutics (CRSP) $69 — The TRUTH Behind the $600M Move Wall Street Is Hiding!
Crispr Therapeutics (CRSP) $69 — The TRUTH Behind the $600M Move Wall Street Is Hiding!
Стоят ли акции CRISPR Therapeutics шумихи?
Стоят ли акции CRISPR Therapeutics шумихи?
CRISPR's Next Advance Is Bigger Than You Think | Jennifer Doudna | TED
CRISPR's Next Advance Is Bigger Than You Think | Jennifer Doudna | TED
Я иду ва-банк: следующая Tesla Кэти Вуд? Эти 3 акции вырастут в 15 раз к 2030 году
Я иду ва-банк: следующая Tesla Кэти Вуд? Эти 3 акции вырастут в 15 раз к 2030 году
CRSP Stock: The Quiet Before a Breakout (or Breakdown)
CRSP Stock: The Quiet Before a Breakout (or Breakdown)
Intellia CEO on Crispr gene-editing treatment, secondary offering
Intellia CEO on Crispr gene-editing treatment, secondary offering
CRISPR Explained
CRISPR Explained
Cathie Wood: “This Will 15X by 2030”
Cathie Wood: “This Will 15X by 2030”
CNBC Disruptor 50: ElevateBio CEO Ger Brophy on AI and CRISPR for rare disease treatments
CNBC Disruptor 50: ElevateBio CEO Ger Brophy on AI and CRISPR for rare disease treatments
Top 4 CRISPR Stocks to Buy in 2026: Massive Growth Potential Ahead?
Top 4 CRISPR Stocks to Buy in 2026: Massive Growth Potential Ahead?
CRISPR Therapeutics explained: Kesgevi, in vivo pipeline, risks and upside
CRISPR Therapeutics explained: Kesgevi, in vivo pipeline, risks and upside
Cathie Wood on CRISPR & Genomic Stocks
Cathie Wood on CRISPR & Genomic Stocks
Cathie Wood Bet Big:
Cathie Wood Bet Big: "This Will 15X by 2030"
CRISPR No Hype Stock Analysis. $CRSP stock analysis. CRISPR Therapeutics for investors.
CRISPR No Hype Stock Analysis. $CRSP stock analysis. CRISPR Therapeutics for investors.
Should You Invest in CRISPR Therapeutics (CRSP) Stock? | The Gene Editing Revolution
Should You Invest in CRISPR Therapeutics (CRSP) Stock? | The Gene Editing Revolution
It's Obvious CRISPR Companies Are Next, They Undervalued the DAWN Drug | Martin Shkreli
It's Obvious CRISPR Companies Are Next, They Undervalued the DAWN Drug | Martin Shkreli
The Next Trillion Dollar Industry: Investing in CRISPR & Biotech
The Next Trillion Dollar Industry: Investing in CRISPR & Biotech